Get research updatesPublic study records, presented in a clearer and more patient-friendly format for mental health research discovery.
A Multicenter, Randomized, Double-Blind, Controlled Study Evaluating the Efficacy and Safety of a Digital Therapeutic as an Adjunct to Treatment as Usual Among Women With Mild to Moderate Postpartum Depression
This study ended early.
Multiple locations, including Lafayette
Complementary Treatment With Procaine Periarticular Injections for Pain Reduction and Functional Improvement in Elderly Individuals With Osteoarthritis
This study has finished and is no longer accepting participants.
In Bucharest
#KindGirlsInACTion: A School-based Intervention to Promote Compassive Competences and Psychological Flexibility in Female Adolescents
This study has finished and is no longer accepting participants.
In CoimbraIn clients with eating disorders, does CBT-T, compared with a wait-list control period, increase the rate of remission?
This study has finished and is no longer accepting participants.
In Australia12 Month Open Extension Study of TNS for ADHD .
This study has finished and is no longer accepting participants.
In Los Angeles12 Week Open Label, Multicenter, Non-Comparative Switch Study Evaluating Efficacy, Tolerability And Safety Of Oral Ziprasidone In Treatment Of Patients Suffering From Schizophrenia Who Have Already Been Treated With An Other Antipsychotic.
This study ended early.
Multiple locations, including BudapestA Phase 3, Randomized, Placebo-Controlled, Double-Blinded Trial Evaluating the Safety and Efficacy of Asenapine in Subjects Continuing Lithium or Valproic Acid/Divalproex Sodium for the Treatment of an Acute Manic or Mixed Episode
This study has finished and is no longer accepting participants.
Location not clearly listed12- Week Open Label Treatment of Refractory Bipolar Depression (BD) With Combination of Depakote ER (DEP) and Aripiprazole (AZP)
This study has finished and is no longer accepting participants.
In San AntonioPragmatic Patient-Oriented 12-Month Extension Study of Dialectical Behavior Therapy for Youth With Bipolar Disorder
This study has finished and is no longer accepting participants.
In TorontoThis study has finished and is no longer accepting participants.
In AlbuquerqueA 12-Week Open-Label Extension Study to Evaluate TNX-102 SL Taken Daily at Bedtime in Patients With PTSD
This study ended early.
Multiple locations, including PhoenixA Multisite, Fixed Dose, Randomized, Double-Blind, Placebo-Controlled 12-Week Study Evaluating the Efficacy, Safety, and Tolerability of Adjunctive Infliximab for the Treatment of Bipolar I/II Depression
This study has finished and is no longer accepting participants.
Multiple locations, including Palo AltoWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.